Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies
Charles D. Murin(Scripps Research Institute), Andrew B. Ward(Scripps Research Institute), Kai Huang(Galveston College), Philipp A. Ilinykh(Houston Methodist), Pavlo Gilchuk(AstraZeneca (Japan)), Lauren E. Williamson(Vanderbilt University Medical Center), James E. Crowe(Vanderbilt University Medical Center), Tanwee Alkutkar(Scripps Research Institute), Edgar Davidson(Integral Molecular (United States)), Aubrey L. Bryan(Integral Molecular (United States)), Benjamin J. Doranz(Integral Molecular (United States)), Xiaoli Shen(Nanchang University), Jeffrey Copps(Scripps Research Institute), Andrew I. Flyak(Vanderbilt University), Alexander Bukreyev(Galveston College), Jessica F. Bruhn(NanoImaging Services), Natalia A. Kuzmina(Galveston College)
Cited by 33
Related Papers
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
|Nature Communications|2019|948